Mack Gene 4
4 · Gain Therapeutics, Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
Mack Gene
DirectorCEO, President
Transactions
- Award
Stock Option (right to buy)
2025-01-06+271,325→ 271,325 totalExercise: $2.44Exp: 2035-01-06→ Common Stock (271,325 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest as to 25% on January 6, 2026 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.